Fineline Cube

Follow:
14389 Articles
Policy / Regulatory

FDA Cracks Down on Compounded GLP-1 APIs; Novo Nordisk Sues Hims & Hers for Patent Infringement

Policy / Regulatory

China’s NHSA Launches Reference Drug Pre-Communication System to Streamline Reimbursement Pathway

AstraZeneca Reports 8% Revenue Growth to $58.7 Billion in 2025; Oncology Leads with 17% Surge
Company

AstraZeneca Reports 8% Revenue Growth to $58.7 Billion in 2025; Oncology Leads with 17% Surge

Gilead Reports 2025 Revenue Growth to $29.4 Billion on HIV Strength; Veklury Plunges 49%
Company

Gilead Reports 2025 Revenue Growth to $29.4 Billion on HIV Strength; Veklury Plunges 49%

Pfizer’s Cresemba Wins NMPA Pediatric Approval for Invasive Fungal Infections
CompanyDrug

Pfizer’s Cresemba Wins NMPA Pediatric Approval for Invasive Fungal Infections

Eli Lilly’s Omvoh Wins NMPA Approval for Crohn’s Disease and Ulcerative Colitis in China
CompanyDrug

Eli Lilly’s Omvoh Wins NMPA Approval for Crohn’s Disease and Ulcerative Colitis in China

CompanyDeals

China Resources Pharma to Divest 17.87% Stake in Tianmai Bio for $205 Million

CompanyDrug

Changchun High-Tech’s GenSci136 Wins NMPA Approval for IgA Nephropathy Clinical Trial

CompanyDrug

Sanofi’s Wayrilz Wins FDA Breakthrough and Japan Orphan Designation for Rare Blood Disorder

Tangji Medtech Files Hong Kong IPO for First NMPA-Approved Endoscopic Obesity Device
CompanyDeals

Tangji Medtech Files Hong Kong IPO for First NMPA-Approved Endoscopic Obesity Device

CompanyDrug

Eisai Biogen’s LEQEMBI Subcutaneous Autoinjector Wins NMPA Priority Review in China

Takeda Enters $1.7 Billion AI Drug Discovery Partnership with Iambic Therapeutics
CompanyDeals

Takeda Enters $1.7 Billion AI Drug Discovery Partnership with Iambic Therapeutics